Remegen Co., Ltd.

This study is for adults with advanced squamous non-small cell lung cancer who haven't had prior treatment. It compares two different drug combinations: a new drug called RC148 plus standard chemotherapy versus an existing drug called tislelizumab plus the same chemotherapy. The …

This study is testing whether a new drug called RC148, when combined with standard chemotherapy, works better than the current standard treatment for advanced colorectal cancer that has spread or cannot be surgically removed. It will involve about 700 adults who have not yet rece…